|
AFF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.8898000000186E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.200060E-03 |
| Normal-vs-Stage2 |
1.217800E-03 |
| Normal-vs-Stage3 |
5.94850000368297E-08 |
| Normal-vs-Stage4 |
3.98219999999672E-05 |
| Stage1-vs-Stage2 |
3.022600E-01 |
| Stage1-vs-Stage3 |
4.196600E-03 |
| Stage1-vs-Stage4 |
4.773700E-02 |
| Stage2-vs-Stage3 |
3.246200E-01 |
| Stage2-vs-Stage4 |
5.879200E-01 |
| Stage3-vs-Stage4 |
7.131600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53947000000043E-05 |
| Normal-vs-AfricanAmerican |
7.362800E-04 |
| Normal-vs-Asian |
1.124000E-01 |
| Caucasian-vs-AfricanAmerican |
8.530400E-01 |
| Caucasian-vs-Asian |
9.779800E-01 |
| AfricanAmerican-vs-Asian |
9.239400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.9025999999922E-05 |
| Normal-vs-Female |
5.88889999999509E-05 |
| Male-vs-Female |
3.933400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.769800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.029900E-04 |
| Normal-vs-Age(61-80Yrs) |
3.50110000002513E-06 |
| Normal-vs-Age(81-100Yrs) |
3.451800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.971200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.804600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.180000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.809400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.305800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.187800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.965000E-01 |
| Normal-vs-Grade 2 |
2.341300E-03 |
| Normal-vs-Grade 3 |
2.58740000003144E-06 |
| Normal-vs-Grade 4 |
1.5607000136697E-09 |
| Grade 1-vs-Grade 2 |
2.212300E-02 |
| Grade 1-vs-Grade 3 |
2.015000E-03 |
| Grade 1-vs-Grade 4 |
1.55408999999995E-05 |
| Grade 2-vs-Grade 3 |
3.288100E-02 |
| Grade 2-vs-Grade 4 |
1.191480E-04 |
| Grade 3-vs-Grade 4 |
2.014000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.446000E-02 |
| Normal-vs-ccB subtype |
1.03349995228541E-09 |
| ccA subtype-vs-ccB subtype |
8.77109995744974E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.16519999999676E-05 |
| Normal-vs-N1 |
6.777200E-03 |
| N0-vs-N1 |
5.051200E-01 |
|
|
